{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:59:45Z","timestamp":1793037585173,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013227","name":"Health Promotion Administration Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1081116"],"award-info":[{"award-number":["A1081116"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1101117"],"award-info":[{"award-number":["A1101117"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.aohep.2025.101943","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:55:14Z","timestamp":1754441714000},"page":"101943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011\u20132019"],"prefix":"10.1016","volume":"30","author":[{"given":"Kwong-Ming","family":"Kee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsang-Wu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gar-Yang","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ju","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Che","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Fu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsang-En","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Ying","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Shen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ju","family":"Ch\u2019ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ping","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5493-4752","authenticated-orcid":false,"given":"Sheng-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.aohep.2025.101943_bib0001","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.aohep.2025.101943_bib0002","unstructured":"Taiwan Cancer Registry Center. Cancer stastistics, https:\/\/twcr.tw\/?page_id=1855&lang=en; [accessed Cite date: March 31, 2023."},{"issue":"3","key":"10.1016\/j.aohep.2025.101943_bib0003","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.101943_bib0004","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.101943_bib0005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2025.101943_bib0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.aohep.2025.101943_bib0007","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jfma.2020.10.031","article-title":"Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan","volume":"120","author":"Shao","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.aohep.2025.101943_bib0008","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jfma.2017.09.007","article-title":"Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan","volume":"117","year":"2018","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.aohep.2025.101943_bib0009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000514174","article-title":"Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update","volume":"10","author":"Kudo","year":"2021","journal-title":"Liver Cancer"},{"issue":"12","key":"10.1016\/j.aohep.2025.101943_bib0010","first-page":"1126","article-title":"Practice guidelines for the management of hepatocellular carcinoma","volume":"23","year":"2022","journal-title":"Kor J Radiol: Official J Korean Radiol Soc"},{"issue":"7","key":"10.1016\/j.aohep.2025.101943_bib0011","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.aohep.2025.101943_bib0012","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/liv.12818","article-title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.aohep.2025.101943_bib0013","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1440-1746.2006.04425.x","article-title":"Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan","volume":"21","author":"Chen","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2025.101943_bib0014","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ejca.2008.02.018","article-title":"The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - survival analysis of 3892 patients","volume":"44","author":"Wang","year":"2008","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.aohep.2025.101943_bib0015","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jfma.2019.01.012","article-title":"Taiwan's nationwide cancer registry system of 40 years: past, present, and future","volume":"118","author":"Chiang","year":"2019","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.aohep.2025.101943_bib0016","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jjco\/hyu211","article-title":"Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review","volume":"45","author":"Chiang","year":"2015","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.aohep.2025.101943_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/v15010126","article-title":"Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019","volume":"15","author":"Kee","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.aohep.2025.101943_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2009.12.018","article-title":"Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis","volume":"46","author":"Kuo","year":"2010","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.aohep.2025.101943_bib0019","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/gutjnl-2014-308786","article-title":"Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.aohep.2025.101943_bib0020","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.32613","article-title":"Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti-VEGF\/TKI and immunotherapy","volume":"76","author":"Tran","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2025.101943_bib0021","article-title":"UNOS down-staging criteria for liver transplantation of hepatocellular carcinoma: systematic review and meta-analysis of 25 studies","author":"Tan","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.101943_bib0022","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2011.05.020","article-title":"Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early\/early stage hepatocellular carcinoma","volume":"56","author":"Wang","year":"2012","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.101943_bib0023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MEG.0000000000000012","article-title":"Liver resection and radiofrequency ablation of very early hepatocellular carcinoma cases (single nodule <2 cm): a single-center study","volume":"26","author":"Zhou","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.101943_bib0024","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cgh.2010.08.018","article-title":"Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas","volume":"9","author":"Hung","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.101943_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000521665","article-title":"Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF Trial)","volume":"11","author":"Takayama","year":"2022","journal-title":"Liver Cancer"},{"issue":"8","key":"10.1016\/j.aohep.2025.101943_bib0026","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/bjs.9539","article-title":"Quality of life after surgical resection compared with radiofrequency ablation for small hepatocellular carcinomas","volume":"101","author":"Huang","year":"2014","journal-title":"Br J Surg"},{"issue":"37","key":"10.1016\/j.aohep.2025.101943_bib0027","doi-asserted-by":"crossref","first-page":"61203","DOI":"10.18632\/oncotarget.18049","article-title":"Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma \u2264 5 cm without macrovascular invasion","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.aohep.2025.101943_bib0028","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.sla.0000114215.03112.e0","article-title":"Favorable surgical outcomes in patients with early hepatocellular carcinoma","volume":"239","author":"Yamamoto","year":"2004","journal-title":"Ann Surg"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2025.101943_bib0029","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000333257","article-title":"Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan","volume":"81","author":"Kee","year":"2011","journal-title":"Oncology"},{"issue":"10","key":"10.1016\/j.aohep.2025.101943_bib0030","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.jfma.2022.04.001","article-title":"Reappraisal of the roles of alpha-fetoprotein in hepatocellular carcinoma surveillance using large-scale nationwide database and hospital-based information","volume":"121","author":"Lin","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"10.1016\/j.aohep.2025.101943_bib0031","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000449336","article-title":"Surgery for intermediate and advanced hepatocellular carcinoma: a consensus report from the 5th Asia-Pacific primary liver cancer Expert meeting (APPLE 2014)","volume":"5","author":"Ho","year":"2016","journal-title":"Liver Cancer"},{"issue":"5","key":"10.1016\/j.aohep.2025.101943_bib0032","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12072-018-9888-4","article-title":"Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver cancer stage B hepatocellular carcinoma","volume":"12","author":"Yang","year":"2018","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.aohep.2025.101943_bib0033","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.dld.2012.10.019","article-title":"Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C","volume":"45","author":"Wang","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.aohep.2025.101943_bib0034","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.29883","article-title":"Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: a meta-analysis of high-quality studies","volume":"68","author":"Hyun","year":"2018","journal-title":"Hepatology"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125001681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125001681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T09:31:12Z","timestamp":1764667872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125001681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1665268125001681"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101943","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011\u20132019","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101943"}}